GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY

ABSTRACT: In the aging population, the longitudinal decrease in the secretion of steroidal and polypeptides growth hormones is directly associated with accumulation of senescent cells in tissues and organs. The cellular hypo-replicative senescence state is caused by metabolic stress and persistent D...

Full description

Bibliographic Details
Main Authors: José E Belizário, Miguel Garay-Malpartida
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Clinical Immunology Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772613423000045
_version_ 1797796346677166080
author José E Belizário
Miguel Garay-Malpartida
author_facet José E Belizário
Miguel Garay-Malpartida
author_sort José E Belizário
collection DOAJ
description ABSTRACT: In the aging population, the longitudinal decrease in the secretion of steroidal and polypeptides growth hormones is directly associated with accumulation of senescent cells in tissues and organs. The cellular hypo-replicative senescence state is caused by metabolic stress and persistent DNA damage, which lead to the activation of the p16INK4a cell-cycle inhibitor, retinoblastoma and p53 pathways. Aging increases the susceptibility to physical frailty, sarcopenia, diabetes, atherosclerosis, infectious disease and cancer in the older adults. As a consequence of immunosenescence and reduced immunoreactivity of the innate and adaptive systems, seniors have a weak response to vaccination. The high doses of vaccines have been recommended to boost growth and activation of memory T and B cells in non-responsive older individuals, but it is not sufficient for long-term protection. The treatment with recombinant human growth hormone has been shown to regenerate thymus and increase the repertoire of naive T cells CD4+ and CD8+ T cell and B cell subsets in people with age-related diseases, chronic viral infection and immunodeficiencies. This review presents an update on senescence biology and their clinical immunological manifestations in the elderly. We describe possible immune mechanisms by which personalized recombinant growth hormone therapy could act to prolong the effectiveness of the vaccines recommended to older adults.
first_indexed 2024-03-13T03:31:41Z
format Article
id doaj.art-b65e32a76a984cd6bb4014eb02e47cc9
institution Directory Open Access Journal
issn 2772-6134
language English
last_indexed 2024-03-13T03:31:41Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Clinical Immunology Communications
spelling doaj.art-b65e32a76a984cd6bb4014eb02e47cc92023-06-24T05:20:03ZengElsevierClinical Immunology Communications2772-61342023-12-0135157GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLYJosé E Belizário0Miguel Garay-Malpartida1Correspondent author; School of Arts, Sciences and Humanity of the University of São Paulo, Rua Arlindo Bettio, 1000, São Paulo, SP, CEP 03828-000School of Arts, Sciences and Humanity of the University of São Paulo, Rua Arlindo Bettio, 1000, São Paulo, SP, CEP 03828-000ABSTRACT: In the aging population, the longitudinal decrease in the secretion of steroidal and polypeptides growth hormones is directly associated with accumulation of senescent cells in tissues and organs. The cellular hypo-replicative senescence state is caused by metabolic stress and persistent DNA damage, which lead to the activation of the p16INK4a cell-cycle inhibitor, retinoblastoma and p53 pathways. Aging increases the susceptibility to physical frailty, sarcopenia, diabetes, atherosclerosis, infectious disease and cancer in the older adults. As a consequence of immunosenescence and reduced immunoreactivity of the innate and adaptive systems, seniors have a weak response to vaccination. The high doses of vaccines have been recommended to boost growth and activation of memory T and B cells in non-responsive older individuals, but it is not sufficient for long-term protection. The treatment with recombinant human growth hormone has been shown to regenerate thymus and increase the repertoire of naive T cells CD4+ and CD8+ T cell and B cell subsets in people with age-related diseases, chronic viral infection and immunodeficiencies. This review presents an update on senescence biology and their clinical immunological manifestations in the elderly. We describe possible immune mechanisms by which personalized recombinant growth hormone therapy could act to prolong the effectiveness of the vaccines recommended to older adults.http://www.sciencedirect.com/science/article/pii/S2772613423000045aginggrowth hormoneimmunosenescenceinflammagingvaccineselderly
spellingShingle José E Belizário
Miguel Garay-Malpartida
GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY
Clinical Immunology Communications
aging
growth hormone
immunosenescence
inflammaging
vaccines
elderly
title GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY
title_full GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY
title_fullStr GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY
title_full_unstemmed GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY
title_short GROWTH HORMONE, IMMUNOSENESCENCE AND VACCINATION FAILURE IN THE ELDERLY
title_sort growth hormone immunosenescence and vaccination failure in the elderly
topic aging
growth hormone
immunosenescence
inflammaging
vaccines
elderly
url http://www.sciencedirect.com/science/article/pii/S2772613423000045
work_keys_str_mv AT joseebelizario growthhormoneimmunosenescenceandvaccinationfailureintheelderly
AT miguelgaraymalpartida growthhormoneimmunosenescenceandvaccinationfailureintheelderly